Nabriva Therapeutics Stock Forecast - Period Momentum Indicator
NBRVDelisted Stock | USD 1.62 0.01 0.61% |
Nabriva Stock Forecast is based on your current time horizon.
Nabriva |
Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
(0.01) | (0.01) |
Check Nabriva Therapeutics Volatility | Backtest Nabriva Therapeutics | Information Ratio |
Nabriva Therapeutics Trading Date Momentum
On December 02 2024 Nabriva Therapeutics AG was traded for 1.62 at the closing time. The top price for the day was 1.63 and the lowest listed price was 1.62 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.62% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Nabriva Therapeutics to competition
Nabriva Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nabriva Therapeutics stock to make a market-neutral strategy. Peer analysis of Nabriva Therapeutics could also be used in its relative valuation, which is a method of valuing Nabriva Therapeutics by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Nabriva Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Nabriva Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nabriva Therapeutics shares will generate the highest return on investment. By undertsting and applying Nabriva Therapeutics stock market strength indicators, traders can identify Nabriva Therapeutics AG entry and exit signals to maximize returns.
Nabriva Therapeutics Risk Indicators
The analysis of Nabriva Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nabriva Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nabriva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.33 | |||
Semi Deviation | 4.98 | |||
Standard Deviation | 4.83 | |||
Variance | 23.37 | |||
Downside Variance | 30.88 | |||
Semi Variance | 24.78 | |||
Expected Short fall | (3.35) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Nabriva Stock
If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |